Search research articles
Contact Us
Filters
Showing results (21-30 of 63) with videos related to
Page
of 7
Sort By:
Clinical and Experimental Rheumatology
|
May 17, 2000
Arthritis following combined vaccine against diphtheria, polyomyelitis, and tetanus toxoid
J F Maillefert, I Tonolli-Serabian, A Cherasse, et al.
Medecine Et Maladies Infectieuses
|
March 19, 2017
Infectious encephalitis: Management without etiological diagnosis 48hours after onset
P Fillatre, Y Crabol, P Morand, et al.
HIV Clinical Trials
|
October 9, 2001
Therapeutic trials in HIV infection: which benefits for which patients?
L Piroth, J Y Callerot, M Grappin, et al.
Scandinavian Journal of Infectious Diseases
|
August 23, 2001
Incidence of gynecomastia in men infected with HIV and treated with highly active antiretroviral therapy
L Piroth, M Grappin, J M Petit, et al.
Medecine Et Maladies Infectieuses
|
February 10, 2020
Comparative review of imipenem/cilastatin versus meropenem
A Salmon-Rousseau, C Martins, M Blot, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 29, 2006
In-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycin
B Martha, D Croisier, D Durand, et al.
Antimicrobial Agents and Chemotherapy
|
October 3, 1999
Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics
L Piroth, L Martin, A Coulon, et al.
Infectious Diseases Now
|
January 29, 2023
Antibiotic therapy in the emergency room: Optimal prescription is indeed the best
F Moretto, F Catherine, B Martha, et al.
Presse Medicale (Paris, France : 1983)
|
March 27, 1999
[Discontinuing protease inhibitor treatment of HIV-1 patients for intolerance. Longitudinal study of 309 patients]
L Piroth, M Grappin, A Waldner, et al.
Medecine Et Maladies Infectieuses
|
December 26, 2008
[Incidence, prevalence and risk factors for a first infectious complication on a totally implantable venous-access port]
M Crisinel, S Mahy, P Ortega-Debalon, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 63) with videos related to
Sort By:
Page
of 7
Clinical and Experimental Rheumatology
|
May 17, 2000
Arthritis following combined vaccine against diphtheria, polyomyelitis, and tetanus toxoid
J F Maillefert, I Tonolli-Serabian, A Cherasse, et al.
Medecine Et Maladies Infectieuses
|
March 19, 2017
Infectious encephalitis: Management without etiological diagnosis 48hours after onset
P Fillatre, Y Crabol, P Morand, et al.
HIV Clinical Trials
|
October 9, 2001
Therapeutic trials in HIV infection: which benefits for which patients?
L Piroth, J Y Callerot, M Grappin, et al.
Scandinavian Journal of Infectious Diseases
|
August 23, 2001
Incidence of gynecomastia in men infected with HIV and treated with highly active antiretroviral therapy
L Piroth, M Grappin, J M Petit, et al.
Medecine Et Maladies Infectieuses
|
February 10, 2020
Comparative review of imipenem/cilastatin versus meropenem
A Salmon-Rousseau, C Martins, M Blot, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 29, 2006
In-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycin
B Martha, D Croisier, D Durand, et al.
Antimicrobial Agents and Chemotherapy
|
October 3, 1999
Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics
L Piroth, L Martin, A Coulon, et al.
Infectious Diseases Now
|
January 29, 2023
Antibiotic therapy in the emergency room: Optimal prescription is indeed the best
F Moretto, F Catherine, B Martha, et al.
Presse Medicale (Paris, France : 1983)
|
March 27, 1999
[Discontinuing protease inhibitor treatment of HIV-1 patients for intolerance. Longitudinal study of 309 patients]
L Piroth, M Grappin, A Waldner, et al.
Medecine Et Maladies Infectieuses
|
December 26, 2008
[Incidence, prevalence and risk factors for a first infectious complication on a totally implantable venous-access port]
M Crisinel, S Mahy, P Ortega-Debalon, et al.
Page
of 7